- Home
- DGLY vs GLMD Comparison
DGLY vs GLMD Comparison
Compare DGLY & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- GLMD
- Stock Information
- Founded
- DGLY N/A
- GLMD 2000
- Country
- DGLY United States
- GLMD Israel
- Employees
- DGLY N/A
- GLMD N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- DGLY Technology
- GLMD Health Care
- Exchange
- DGLY Nasdaq
- GLMD Nasdaq
- Market Cap
- DGLY 3.9M
- GLMD 4.1M
- IPO Year
- DGLY N/A
- GLMD 2014
- Fundamental
- Price
- DGLY $1.99
- GLMD $1.83
- Analyst Decision
- DGLY
- GLMD Hold
- Analyst Count
- DGLY 0
- GLMD 1
- Target Price
- DGLY N/A
- GLMD N/A
- AVG Volume (30 Days)
- DGLY 96.3K
- GLMD 404.1K
- Earning Date
- DGLY 08-15-2025
- GLMD 08-27-2025
- Dividend Yield
- DGLY N/A
- GLMD N/A
- EPS Growth
- DGLY N/A
- GLMD N/A
- EPS
- DGLY N/A
- GLMD N/A
- Revenue
- DGLY $18,596,715.00
- GLMD N/A
- Revenue This Year
- DGLY N/A
- GLMD N/A
- Revenue Next Year
- DGLY N/A
- GLMD N/A
- P/E Ratio
- DGLY N/A
- GLMD N/A
- Revenue Growth
- DGLY N/A
- GLMD N/A
- 52 Week Low
- DGLY $1.93
- GLMD $1.15
- 52 Week High
- DGLY $246.00
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- DGLY 24.69
- GLMD 48.30
- Support Level
- DGLY $2.07
- GLMD $1.87
- Resistance Level
- DGLY $2.32
- GLMD $2.34
- Average True Range (ATR)
- DGLY 0.11
- GLMD 0.18
- MACD
- DGLY 0.72
- GLMD -0.00
- Stochastic Oscillator
- DGLY 7.32
- GLMD 15.00
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.